21 CFR 4.103
§ 4.103 What information must you share with other constituent part applicants for the combination product?
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 4.103, § 4.103 What information must you share with other constituent part applicants for the combination product?, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/83014
- Permanent ID
ys:prov:83014@1- SHA-256
aa34abcdca6d3a792d1bb01451438adc5f694d94fc73aceb2cc7895077f80282
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) When you receive information regarding an event that involves a death or serious injury as described in § 803.3 of this chapter, or an adverse experience as described in § 314.80(a) of this chapter or § 600.80(a) of this chapter, associated with the use of the combination product, you must provide the information to the other constituent part applicant(s) for the combination product no later than 5 calendar days of your receipt of the information.
(b) With regard to information you must provide to the other constituent part applicant(s) for the combination product, you must maintain records that include:
(1) A copy of the information you provided,
(2) The date the information was received by you,
(3) The date the information was provided to the other constituent part applicant(s), and
(4) The name and address of the other constituent part applicant(s) to whom you provided the information.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.